BLT 0.00% 2.6¢ benitec biopharma limited

Trial time table, page-9

  1. 7,112 Posts.
    lightbulb Created with Sketch. 1406
    Some analysts believe there is still going to be a substantial market for hcv treatments in 2020:

    "Merck has its own blockbuster ambitions--analysts have pegged 2020 sales at $2 billion-plus".

    Maybe this explains the recent buying by Sabby.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.